Novartis India Limited (BOM:500672)
1,362.55
+16.00 (1.19%)
At close: May 22, 2026
Novartis India Revenue
In the fiscal year ending March 31, 2026, Novartis India had annual revenue of 3.54B INR, down -0.54%. Novartis India had revenue of 905.50M in the quarter ending March 31, 2026, with 7.95% growth.
Revenue
3.54B
Revenue Growth
-0.54%
P/S Ratio
9.49
Revenue / Employee
63.27M
Employees
56
Market Cap
33.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.54B | -19.40M | -0.54% |
| Mar 31, 2025 | 3.56B | 212.00M | 6.33% |
| Mar 31, 2024 | 3.35B | -436.70M | -11.53% |
| Mar 31, 2023 | 3.79B | -211.30M | -5.28% |
| Mar 31, 2022 | 4.00B | 185.20M | 4.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Steel Strips Wheels | 49.42B |
| Aarti Drugs | 25.68B |
| Cigniti Technologies | 22.11B |
| GRM Overseas | 14.63B |
| Hind Rectifiers | 10.01B |
| Bhagiradha Chemicals & Industries | 5.38B |
| Marathon Nextgen Realty | 5.31B |
| TechNVision Ventures | 2.42B |
Novartis India News
- 3 months ago - Pharma sector stocks today, Feb 20: Novartis India rally 20%, Biocon jumps 1.36%, Alembic rises 1.11% - Business Upturn
- 3 months ago - Novartis India shares in focus today as mandatory open offer triggered after 70.68% stake deal - Business Upturn
- 3 months ago - Novartis India shares surge 14.65% today after Novartis AG to sell 70.68% stake - Business Upturn
- 1 year ago - Novartis India stock surges 9% as Alkem Labs eyes ₹2,000 crore acquisition - Business Upturn